Chromogenic In Situ Hybridization in Tumor Pathology
Ever since the correlation was found between the pathogenesis of diseases and genomic alterations, molecular cytogenetic techniques have found a place in molecular medicine. These techniques are used in tracing gene and genomic abnormalities that are underlying in the development of cancer and genetic diseases. In 1969, Gall and Pardue introduced a technique known as “in situ hybridization” (ISH) to localize nucleic acids in individual cells (1 ). At that time, the capabilities of ISH were limited to highly repetitive sequences using radioactively labeled probes that were subsequences visualized by autoradiography. The use of radioisotopes has many disadvantages and has been replaced in DNA ISH by nonradioactive detection methods. The most commonly used reporter molecules are haptens, such as biotin and digoxigenin, which can be incorporated easily in the probe DNA. The tagged probes are then detected with labeled antibodies against the specific tag or, as in the case of biotin, with a labeled avidin molecule. Since the first report of fluorescent in situ hybridization (FISH) (2 ), the principle of FISH has remained essentially the same, with the exception that biotin and digoxigenin have partly been replaced by directly fluorochrome-conjugated nucleotides, which simplifies the laboratory protocol.
- MRD Detection in Acute Lymphoblastic Leukemia Patients Using Ig/TCR Gene Rearrangements as Targets for Real-Time Quantitative PC
- Preparation of Retroviral Vectors for Cell-Cycle-Targeted Gene Therapy of Lung Cancer
- Measurement of Telomerase Activity in Human Hematopoietic Cells and Neoplastic Disorders
- Microsatellite Instability Testing
- Isolation of Cells Entering Different Programmed Cell Death Pathways Using a Discontinuous Percoll Gradient
- Antisense Oligonucleotides as Research Tools
- TNF Signaling: Key Protocols
- Determination of Peak Serum Levels and Immune Response to the Humanized Anti-Ganglioside Antibody-Interleukin-2 Immunocytokine
- 螢光素酶載體PGL3轉(zhuǎn)染細胞要不要加G418
- 用LIPO2000轉(zhuǎn)染HepG2細胞的問題